Antibiotics will continue to be effective precisely because they are broad spectrum. A doctor can hit you with an antibiotic before they know exactly what you have.
I am always happy to see new tools in medicine. However, I suspect phages are most going to be used initially in persistent, chronic, antibiotic resistant infections where everything else has failed.
I still think in the cases you describe that they could stand to replace e.g. Vancomycin - BEFORE that fails. The side effect profile for that drug is horrendous: GI bleed, neuro/sensory damage, liver damage, retinal damage etc..
It seems like a blend of phages with slightly varied activity could also reproduce the broad spectrum effect, and CRISPR is going to make that pretty easy I think.